LOGIN  |  REGISTER
Terns Pharmaceuticals
Recursion

Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024

March 06, 2024 | Last Trade: US$7.87 0.03 0.38

Boston, March 06, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, is attending HIMSS 2024, March 11-15, in Orlando, Fla. Company leaders will be in booth #1441 to discuss Amwell’s hybrid care enablement platform, Virtual Nursing solution, automated care and behavioral health programs and how this technology can address workforce shortages, access to care, the mental health crisis and other industry challenges. 

In addition, three Amwell clients will present during two sessions at HIMSS: 

Tuesday, March 12 

  • 10:30 a.m. EST, Room W204A: Tightly Integrating Telehealth for Better Access – Michael Ross, M.D., FAAP, FACMI, vice president and chief medical information officer of Optum Insight, supporting Northern Light Health, will discuss the benefits of a tightly integrated approach to virtual care for large health systems. Northern Light Health uses the Amwell ConvergeTM platform, integrated with its electronic health record, as well as Amwell hardware devices, to support a variety of programs designed to improve patient and provider experiences.  

Wednesday, March 13 

  • 8:30 a.m. EST, Room W207C: Taking a Next-Level Approach to Automated Care: Lessons From Leaders – El Camino Health Chief Information Officer Deb Muro, BSN, MBA, CHCIO, will join Northwell Health’s Clinical Informatics Consultant Kathleen Mazza, Ph.D., RN, MBA, and Associate Chief Medical Officer Zenobia Brown, MD, MPH, in discussing how each health system uses automated care approaches to improve patient outcomes. El Camino Health and Northwell Health use Amwell Automated Care Programs to provide chat-based virtual companions for post-discharge, pre- and post-surgery, chronic conditions, obstetrics and more. 

For more information about Amwell at HIMSS, or to talk with a company leader during the event, contact This email address is being protected from spambots. You need JavaScript enabled to view it.
  
About Amwell

Amwell provides a leading hybrid care enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. The company offers a single, comprehensive platform to support all digital health needs, from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives and many of the nation’s largest health systems. For more information, please visit https://business.amwell.com/.   
   
©2024 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, ConvergeTM, CarepointTM and the Amwell Logo are registered trademarks or trademarks of American Well Corporation.   

Assertio

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB